Zhou Jiang, Translational Research Scientist at MD Anderson Cancer Center, shared on LinkedIn:
“Wrapping up an unforgettable week in Phoenix at SITC26!
This meeting was a special milestone – from presenting our Rapid Oral on targeting TCF7 phosphorylation in solid tumor CAR-T cells (Abstract 931) and be the panelist and mentor of Educational session for STEM students, to receiving a SITC Young Investigator Award and having our study featured in UT MD Anderson official Society for Immunotherapy of Cancer (SITC) highlights.
Even better than the science was the time spent off-stage: reuniting with my SITC Sparkathon cohort and mentors, sharing great meals, and catching up with so many old and new friends across academia and industry.
Heading back to Houston energized for the next phase of this project – looking forward to sharing the next chapter of our story and seeing everyone again at the next SITC!”
You may also be interested in:
Samra Turajlić: Celebrating Max Emmerich’s Recognition at SITC 2026
Shasell Negron։ Exploring the Future of Immuno-Oncology at the CRI Convention
Kristen Hege Inducted as Fellow of the SITC Academy of Immuno-Oncology
